Introduction

This journal package grants pharmacists and healthcare professionals access to the January 2025 issue of The Lancet Global Health.

With 28 peer-reviewed, open-access articles, it ensures you stay informed on the latest global health trends, developments, and research. This resource is essential for keeping up to date with critical advancements in the field.

[Open Access]

Who Should Enrol

All registered pharmacy- and healthcare professionals in Kenya.

Course Content

The January 2025 issue of The Lancet Global Health include the following 28 articles:
(with a curated selection of 10 articles* available for download)

  • Harm reduction must replace punitive drug policies
  • Contraceptive equity: insights from the progress in 48 FP2030 countries
  • Monitoring essential medicines access—unfinished business
  • Relapse after recovery from acute malnutrition
  • Mifepristone–misoprostol intervals: insights into the timing of abortion
  • Community mobilisation and incentives for child health
  • Metrics for access to water and sanitation need structural changes
  • Strategies for more equitable engagement for African researchers
  • Resolving the CD4-testing crisis to help end AIDS-related deaths
  • Global primary care: what it is, what it isn’t, and why it matters to us all
  • Women at the front line of the Marburg virus disease response in Rwanda: balancing clinical care, public health, and family life
  • Improving access to liposomal amphotericin B worldwide
  • Improving access to liposomal amphotericin B worldwide – Authors’ reply
  • Improving access to liposomal amphotericin B worldwide
  • Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction
  • Double stigma among pregnant adolescents living with HIV in sub-Saharan Africa: a call to action
  • Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015–19: a modelling study (Thanzi La Onse) *
  • Progress in reducing socioeconomic inequalities in the use of modern contraceptives in 48 focus countries as part of the FP2030 initiative between 1990 and 2020: a population-based analysis *
  • Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis *
  • Global burden of tuberculous meningitis in children aged 0–14 years in 2019: a mathematical modelling study *
  • Association of current Schistosoma mansoni, Schistosoma japonicum, and Schistosoma mekongi infection status and intensity with periportal fibrosis: a systematic review and meta-analysis *
  • Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda *
  • Rates and risk factors for relapse among children recovered from severe acute malnutrition in Mali, South Sudan, and Somalia: a prospective cohort study *
  • Effectiveness and acceptability of a 24-h interval versus a 48-h interval between mifepristone intake and misoprostol administration for in-hospital abortion at 9–20 gestational weeks: an international, open-label, randomised, controlled, non-inferiority trial *
  • An innovative Community Mobilisation and Community Incentivisation for child health in rural Pakistan (CoMIC): a cluster-randomised, controlled trial*
  • Effect of a community-based intervention for sexually transmitted infections on population-level prevalence among youth in Zimbabwe (STICH): a cluster-randomised trial *
  • The 2024 small island developing states report of the Lancet Countdown on health and climate change
  • Essential shifts in health workforce measurement: a human-centred approach

Certification

The assessment (MCQ) must be successfully completed to receive your certificate - two (2) attempts to achieve 70%.

The Quiz is based on the following article:

  • Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda





Open Access - 28 Articles & Quiz for CPD Certificate included within this Journal Issue (10 articles selected and available for download)